Healthy eating is the first step to making sure that you are getting yourself more fit. There a a lot of great advantages to eating better and these include more energy, better concentration and less stomach and digestive problems. Currently, the typical American diet is low in fruits, vegetables, and whole grains, and high in saturated fat, salt, and sugar. As a result, more Americans than ever are overweight, obese, and at increased risk for chronic diseases such as heart disease, high blood pressure, diabetes, and certain cancers.

Older people are most likely to improve their eating habits, but nutrition is important for people of all ages, says Walter Willet, M.D., chairman of the nutrition department at the Harvard School of Public Health. “We know that when people have health problems or their friends become ill, these are strong motivators of change,” says Willet. “The more serious the health condition, the more serious the change. We’d rather people made changes early and prevent health problems in the first place.”

So what if you’re feeling trapped by a diet full of fast-food burgers and cookies? You can work your way out slowly but surely. Here are tips to move your eating habits in the right direction.
Read the rest of this entry »

Looking to make a change and lose some weight? I have reviewed the top diet on the internet and you can go and read over 200 comments people have made about why this diet has worked well for them, as well as some of the problems.

Tags: and Blood Institute, and Dietary Supplements, baked whole-grain corn tortilla chips, Barbara Schneeman, broil food, cancers, Chairman, chairman of the nutrition department, Cindy Moore, Cleveland Clinic Foundation, corn tortilla chips, diabetes, director, director of nutrition therapy, energy, Eric Hentges, fat-free products, food, Food and Drug Administration's Office of Nutritional Products, food diary, food groups, food package, food product, food products, grain products, Harvard School of Public Health, heart disease, high blood pressure, hypertension, kidney disease, Labeling, lower-salt products, Lung, make smart food choices, Marilyn Tanner, milk products, National Heart, nutrition therapy, pediatric dietitian, physician, potassium chloride, similar products, squash, St. Louis, stroke, Tennis, USDA Center for Nutrition Policy and Promotion, vegetable oil, Walter Willet, Washington University School of Medicine

Being more physically fit appears to slow down damage to the brain’s memory centers in the early stages of Alzheimer’s disease, according to a study conducted by researchers from the University of Kansas Medical Center and presented at the Alzheimer’s Association International Conference on Alzheimer’s Disease in Chicago.

“This is the first study to get an inside look into specifically where these changes occur in the brain,” lead researcher Robyn Honea said. “We’re able to locate the changes associated with fitness to the actual memory region, the hippocampus, which is a key area for Alzheimer’s-related atrophy.”

Researchers conducted magnetic resonance imaging (MRI) brain scans on 60 adults over the age of 60 who were in the early stages of Alzheimer’s disease, along with 56 who did not have any form of dementia. All participants also took part in tests of oxygen consumption during a treadmill exercise, as a measure of overall cardiovascular fitness. Read the rest of this entry »

Tags: Alzheimer's, Alzheimer's Association, Alzheimer's disease, Association's Medical and Scientific Advisory Council, Chairman, Chicago, dementia, lead researcher, magnetic resonance imaging, MRI, Robyn Honea, Sam Gandy, University of Kansas Medical Center, www.reuters.com

We have all seen the pills in the stores that promise that we will lose weight fast by taking them and i have never believed them although millions have been spent on them. Now finally the US Federal Trade Commission has settled with the makers of some of these products by saying that they can not use misleading claims and have been fined as well.

The FTC has filed complaints in four separate cases alleging that weight-loss and weight-control claims were not supported by competent and reliable scientific evidence. Marketers of the four products –Xenadrine EFX, CortiSlim, TrimSpa, and One-A-Day WeightSmart – have settled with the FTC, surrendered cash and other assets worth at least $25 million, and agreed to limit their future advertising claims.

“You won’t find weight loss in a bottle of pills that claims it has the latest scientific breakthrough or miracle ingredient,” said FTC Chairman Deborah Platt Majoras. “Paying for fad science is a good way to lose cash, not pounds.”

Two marketers of Xenadrine EFX will pay at least $8 million and as much as $12.8 million to settle FTC allegations that Xenadrine EFX’s weight-loss claims were false and unsubstantiated. The funds will be used for consumer redress. In a bankruptcy case not involving the Commission, the defendants have also agreed to pay at least an additional $22.75 million to settle claims brought by creditors and consumers, including personal injury claims for an earlier ephedra-based product.

Xenadrine EFX, which contains, among other ingredients, green tea extract (EGCG), caffeine, and bitter orange (Citrus aurantium), was advertised heavily in print and on television, including in such publications as People, TV Guide, Cosmopolitan, and Men’s Fitness. Xenadrine EFX advertising also appeared in Spanish-language publications.

The FTC’s complaint alleged that the defendants made false or unsubstantiated claims for Xenadrine EFX, including that it was clinically proven to cause rapid and substantial weight loss and clinically proven to be more effective than leading ephedrine-based diet products. According
to the complaint, Robert Chinery commissioned several studies of Xenadrine EFX, none of which showed substantial weight loss. The complaint alleged that in one of these studies, subjects taking Xenadrine EFX lost an average of only 1.5 pounds over the 10-week study, while a control group taking a placebo lost an average of 2.5 pounds over the same period.

The complaint also alleged that Xenadrine EFX advertisements falsely represented that persons appearing in the ads achieved the reported weight loss solely by using Xenadrine EFX. According to the FTC complaint, consumer endorsers lost weight by engaging in rigorous diet and/or exercise programs. In addition, the endorsers were paid from $1,000 to $20,000 in connection with their testimonials; according to the complaint, Xenadrine EFX advertisements failed to disclose those payments.

This is a good news story as it is perfectly timed to point out these products as not being nearly as effective at a time of year when many people are looking for a shortcut to weight loss as part of new years resolutions.

Tags: advertising claims, Chairman, Deborah Platt Majoras, earlier ephedra-based product, ephedrine-based diet products, Federal Trade Commission, Robert Chinery, TV Guide, US Federal Trade Commission, USD

What is Glivec? It seems that w3e always hear cancer storeis and that there are not very many good news stories, not that I usually see anyway. Leukemia is a type of blood cancer that is often fatal and I had not ever heard of any drug therapies that were remarkable until I saw a news result today out of England that said that many people taking the drug Glivec are having amazing results. Here is some info on this Drug from Medical News Today.

Most patients who develop chronic myeloid leukaemia (CML) can now expect to live more than 20 years from diagnosis if they are treated with the tyrosine kinase inhibitor (TKI) Glivec (imatinib) according to haematologists involved in the IRIS (International Randomized Interferon versus STI571) study. Before availability of current treatments, median survival from diagnosis was 3.5 years.

Around 95 per cent of patients diagnosed with CML have the Philadelphia chromosome positive (Ph+) form that responds well to Glivec, said Professor John Goldman, professor of haematology at Imperial College, London. The chromosome is the result of translocation between the long arms of chromosomes 9 and 22. Part of the breakpoint cluster region (Bcr) gene from chromosome 22 fuses with part of the abelson leukaemia virus (Abl) gene on chromosome 9 producing the abnormal tyrosine kinase protein Bcr-Abl. It is this protein that causes the proliferation of white blood cells resulting in CML.

Four-year data from IRIS were presented at this year’s American Society of Hematology (ASH) meeting. More than 90 per cent of patients with Ph+ CML in the chronic phase, randomised initially to Glivec 400mg daily in the year 2000, were still alive and free of progression to advanced disease at 54 months, Professor Goldman said.

The study confirmed that patients who achieved a major molecular response within one year, ie, a more than 1000-fold reduction in residual leukaemia, fared best. Patients achieving a three-log reduction in Bcr-Abl transcript levels within oneyear were all free of progression to advanced disease at year four.
Read the rest of this entry »

Tags: advanced disease, American Society of Hematology, cancer, Chairman, diabetes, drug therapies, France, Francois Guilhot, Glivec What, Glivec-resistant, Hagop Kantarjian, Imperial College, John Goldman, leukaemia, Leukemia, London, Novartis, Philadelphia, professor, professor of haematology, professor of oncology, Texas, United Kingdom, University of Poitiers